CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients

NCT04734873 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

46

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision. Not related to safety issues.

Conditions

Covid-19

Interventions

DRUG: CPI-006 2 mg/kg + SOC
DRUG: CPI-006 1 mg/kg + SOC
DRUG: Placebo + SOC

Sponsor

Corvus Pharmaceuticals, Inc.